ACAD
38.36
-0.54
-1.39%
AEMD
0.196
-0.01
-4.6341%
APRI
1.61
-0.13
-7.47%
ARNA
4.49
+0.05
+1.13%
ATEC
1.41
+0.01
+0.71%
CNAT
6.66
-0.15
-2.20%
CRXM
0.354
-0.007
-1.8056%
CYTX
0.985
+0.002
+0.183%
DXCM
69.43
-1.13
-1.60%
GNMK
10.69
-0.24
-2.20%
HALO
16.86
-0.08
-0.50%
ILMN
189.59
-3.01
-1.56%
INNV
0.145
-0.008
-4.918%
INO
10.35
-0.25
-2.36%
ISCO
0.074
+0.004
+5.714%
ISIS
66.37
-1.38
-2.03%
LGND
89.75
+0.83
+0.93%
LPTN
2.23
-0.01
-0.45%
MBVX
3.36
-0.01
-0.30%
MEIP
2.16
-0.02
-0.92%
MNOV
4.09
+0.11
+2.76%
MRTX
27.87
-0.15
-0.54%
MSTX
0.49
0.00
+1.03%
NBIX
43.37
-0.31
-0.71%
NUVA
43.99
+0.23
+0.53%
ONCS
0.268
-0.009
-3.423%
ONVO
5.19
+0.12
+2.37%
OREX
7.36
-0.08
-1.08%
OTIC
31.8
-1.32
-3.99%
QDEL
23.38
-0.43
-1.81%
RCPT
169.885
-1.255
-0.733%
RGLS
17.49
-0.8
-4.37%
RMD
65.7
-7.68
-10.47%
SCIE
0.026
+0.002
+7.9167%
SPHS
0.8
-0.025
-3.0542%
SRNE
10.52
-0.15
-1.41%
TROV
8.8
-0.13
-1.46%
VICL
1.005
-0.025
-2.427%
VOLC
17.99
0.00
0.00%
ZGNX
1.54
-0.11
-6.67%
ACAD
38.36
-0.54
-1.39%
AEMD
0.196
-0.01
-4.6341%
APRI
1.61
-0.13
-7.47%
ARNA
4.49
+0.05
+1.13%
ATEC
1.41
+0.01
+0.71%
CNAT
6.66
-0.15
-2.20%
CRXM
0.354
-0.007
-1.8056%
CYTX
0.985
+0.002
+0.183%
DXCM
69.43
-1.13
-1.60%
GNMK
10.69
-0.24
-2.20%
HALO
16.86
-0.08
-0.50%
ILMN
189.59
-3.01
-1.56%
INNV
0.145
-0.008
-4.918%
INO
10.35
-0.25
-2.36%
ISCO
0.074
+0.004
+5.714%
ISIS
66.37
-1.38
-2.03%
LGND
89.75
+0.83
+0.93%
LPTN
2.23
-0.01
-0.45%
MBVX
3.36
-0.01
-0.30%
MEIP
2.16
-0.02
-0.92%
MNOV
4.09
+0.11
+2.76%
MRTX
27.87
-0.15
-0.54%
MSTX
0.49
0.00
+1.03%
NBIX
43.37
-0.31
-0.71%
NUVA
43.99
+0.23
+0.53%
ONCS
0.268
-0.009
-3.423%
ONVO
5.19
+0.12
+2.37%
OREX
7.36
-0.08
-1.08%
OTIC
31.8
-1.32
-3.99%
QDEL
23.38
-0.43
-1.81%
RCPT
169.885
-1.255
-0.733%
RGLS
17.49
-0.8
-4.37%
RMD
65.7
-7.68
-10.47%
SCIE
0.026
+0.002
+7.9167%
SPHS
0.8
-0.025
-3.0542%
SRNE
10.52
-0.15
-1.41%
TROV
8.8
-0.13
-1.46%
VICL
1.005
-0.025
-2.427%
VOLC
17.99
0.00
0.00%
ZGNX
1.54
-0.11
-6.67%
Home » SDBN Blog, SDBN Feed

Regulus Therapeutics to be Featured at April 30th Event

Submitted by on March 29, 2009 – 10:18 am

SDBN’s April event will feature Regulus Therapeutics, an exciting new company focused on the development and commercialization of microRNA therapeutics. SDBN events are the only place you can learn about the hottest scientific research in San Diego, and also have plenty of time to network with 100+ biotechnology professionals.

For more information about Regulus Therapeutics, see their fact sheet (PDF). Bal Bhat, Ph.D., Senior Director, Medicinal Chemistry, will give a 15 minute presentation on Therapeutic Targeting of microRNAs, and you’ll get a chance to talk with him along with others from the company who will be attending.

[print_link]

Event Details
Who: Biotechnology professionals in the greater San Diego area
What: San Diego Biotechnology Network April Event Featuring Regulus Therapeutics
When: Thursday, April 30th, 5:30-9:00 p.m.
Where: Tango Del Rey, 3567 Del Rey Street, San Diego 92109 (Directions below)
Cost: $20, including appetizers ($15 for Academics) +$5 at door
Contact: http://sdbn.org/contact
For more information about the event: http://sdbn.org/april

Directions: From the North: South on Interstate 5, Exit Balboa Ave, Straight to 4th Traffic Light then left on Bunker Hill St. Building directly ahead 3 blks. From the South: North on Interstate 5, Exit Grand/ Garnet Ave, Straight to 3rd Traffic Light then right on Bunker Hill St. Building directly ahead 3 blks.

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.


+ five = 6